Related Experiment Video
Updated: Sep 13, 2025

05:37
Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
Published on: May 31, 2018
12.3K
Tamarixetin: A Promising Bioflavonoid Against Acetaminophen-Induced Liver Injury
Mehmet Ali Telafarlı1, Ejder Saylav Bora2, Firdes Topal3
1Department of Emergency Medicine, Erzurum City Hospital, 25240 Erzurum, Turkey.
Current Issues in Molecular Biology
|July 29, 2025
Summary
Tamarixetin (Trx) shows significant hepatoprotection against acetaminophen (APAP) overdose in rats. This natural flavonoid reduces liver damage by acting as an antioxidant and anti-inflammatory agent, suggesting potential for clinical trials.
Area of Science:
- Hepatology
- Toxicology
- Pharmacology
Background:
- Acetaminophen (APAP) overdose is a leading cause of acute liver failure, primarily driven by oxidative stress, mitochondrial dysfunction, and inflammation.
- Tamarixetin (Trx), a flavonoid with known antioxidant and anti-inflammatory properties, has not been previously investigated for its effects on APAP-induced hepatotoxicity.
Purpose of the Study:
- To evaluate the potential hepatoprotective effects of Tamarixetin (Trx) against acetaminophen (APAP)-induced liver injury in a rat model.
- To investigate the underlying mechanisms of Trx's action, focusing on oxidative stress and inflammatory markers.
Main Methods:
- Male Wistar rats were divided into control, APAP + saline, and APAP + Trx groups.
- Hepatotoxicity was induced by a single intraperitoneal dose of APAP (300 mg/kg).
- Trx (3 mg/kg/day) was administered intraperitoneally for 3 days prior to APAP administration.
- Biochemical (ALT, MDA, GSH, thioredoxin), oxidative stress, and histopathological parameters were assessed in blood and liver tissues.
Main Results:
- APAP overdose significantly depleted hepatic glutathione (GSH) and thioredoxin, increased serum alanine aminotransferase (ALT) and malondialdehyde (MDA), and caused substantial hepatocyte damage.
- Trx treatment markedly reduced serum ALT and MDA levels, decreased the percentage of damaged hepatocytes, and restored hepatic GSH and thioredoxin levels.
- Histopathological examination confirmed significant hepatoprotection in the Trx-treated group, with notably increased HSP-70 expression suggesting modulation of the stress response.
Conclusions:
- Tamarixetin (Trx) demonstrates significant hepatoprotective effects against APAP-induced liver injury in rats.
- The protective mechanisms of Trx likely involve potent antioxidant and anti-inflammatory activities.
- These findings highlight Trx as a potential natural hepatoprotectant, meriting further investigation in clinical settings.
More Related Videos
Related Concept Videos
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
380
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
380
Phase II Reactions: Acetylation Reactions
358
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
358

